Position in VTRS
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$65,021,117
+$61,458,425 QoQ
Shares Held
4,812,814
+1581.9% QoQ
Ownership
0.413%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SG Americas Securities, LLC holds $233,543,492 across 35 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (27.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
This page
|
4,812,814 | $65,021,117 | |
| 2 | ZTS |
Zoetis Inc.
|
290,332 | $34,320,145 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
640,179 | $30,824,618 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
780,518 | $23,509,202 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
377,213 | $19,498,139 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
23,113 | $13,705,546 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
710,876 | $8,836,188 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
59,267 | $7,807,834 |
All Filings in VTRS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $65,021,117 | 4,812,814 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $3,562,692 | 286,160 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $127,403 | 12,869 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,009,679 | 113,066 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,605,862 | 184,370 | Shares | Sole | 2025-04-15 | |
| 2024-09-30 | $4,250,920 | 366,143 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $3,516,265 | 330,787 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,945,694 | 162,956 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $2,363,030 | 218,193 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $1,151,953 | 116,831 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $1,808,445 | 181,207 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $1,106,973 | 115,070 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $3,701,459 | 332,566 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,469,938 | 172,528 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $5,195,025 | 496,182 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,273,329 | 117,034 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $5,680,759 | 419,864 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $2,949,984 | 217,711 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $15,265,592 | 1,068,271 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,021,221 | 144,683 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $6,823,234 | 364,100 | Shares | Sole | 2021-02-04 | |
| No filing history on record for this holder in this stock. | ||||||